Evidence map›Paper›PMID 41869541›Full record

ArticleFrontiers in health services2026

Hybrid type 1 effectiveness-implementation studies: why and how to do them.

Jure Baloh, Sara J Landes, Jeffrey L Smith, Geoffrey M Curran

Abstract read
In one paragraph

Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jure BalohDepartment of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Sara J LandesDepartment of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Jeffrey L SmithBehavioral Health Quality Enhancement Research Initiative (QUERI), Central Arkansas Veterans Healthcare System, Little Rock, AR, United States.
Geoffrey M CurranDepartment of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effectiveness-implementation hybrid type 1 studies primarily investigate the effectiveness of an intervention and have a secondary focus on exploring implementation-related factors. Integrating implementation aims into intervention effectiveness studies can improve the speed, quantity, and quality of intervention implementation, sustainment, and scale in routine practice, and thereby maximize the impact on population health. This article provides guidance for designing and conducting the implementation aims of effectiveness-implementation hybrid type 1 studies, summarizing past thinking and advancing new considerations for these approaches. The authors argue that hybrid type 1 approaches are suitable for most types of intervention effectiveness research (e.g., efficacy trials, comparative-effectiveness research, observational studies), for different kinds of interventions (e.g., treatment, screening, prevention), and in a broad range of settings (e.g., healthcare, public health, community, schools). The article offers methodological guidance for designing the implementation aims of hybrid type 1 studies, structured around three goals: (1) explain intervention implementation in the effectiveness trial, (2) explore stakeholder perceptions to inform future implementation research, and (3) examine stakeholder perceptions to inform the effectiveness trial. Each of these goals offers a distinct set of research questions and design considerations (e.g., timing, sampling, data collection). Finally, the authors provide some tools and resources for planning and designing hybrid type 1 studies.

Indexed as

hybrid effectiveness-implementationhybrid type 1implementationmethodological guidanceresources

Identifiers

PMID41869541
PMCPMC12999578

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.